Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 4:56 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 841–864 of 1,280 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Infection Prophylaxis Clear all

Conditions: Surgical Site Infection
Interventions: Implementation of the AO Trauma SSI Prevention Bundle; Behavioral
Lead sponsor: AO Clinical Investigation and Publishing Documentation; Other
Eligibility: 18 Years to 100 Years
Enrollment: 222 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 8
States / cities: Los Angeles, California • Lexington, Kentucky • Worcester, Massachusetts + 5 more

Conditions: Gustilo-Anderson Type III Open Tibia Fracture
Interventions: Irrisept (Irrigation Solution), Saline; Drug
Lead sponsor: Brett D. Crist; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Frostbite
Interventions: Long-Acting silver dressings, Aloe Vera, Dalbavancin; Device · Other · Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 99 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Home Parenteral Nutrition
Interventions: Caregiving support interventions (FamTechCare); Behavioral
Lead sponsor: University of Kansas; Other
Eligibility: 18 Years and older
Enrollment: 172 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Obesity, Obesity, Morbid, Pregnancy, Infection; Cesarean Section
Interventions: Cefazolin; Drug
Lead sponsor: MemorialCare Health System; Other
Eligibility: Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 2
States / cities: Long Beach, California • Orange, California

Conditions: Covid19
Interventions: Nasal lavage; Other
Lead sponsor: Augusta University; Other
Eligibility: 55 Years and older
Enrollment: 239 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: HIV/AIDS
Interventions: Genvoya; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 49 Years · Male only
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Breast Cancer, Colorectal Cancer, Covid19
Interventions: Informational videos and social media campaigns encouraging cancer screening.; Behavioral
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Pawtucket, Rhode Island

Conditions: HIV Infections
Interventions: TriGrid™ Delivery System, conventional intramuscular injection; Device
Lead sponsor: Rockefeller University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Short Bowel Syndrome
Interventions: rtPA lock therapy; Drug
Lead sponsor: Lynn Malec; Other
Eligibility: 6 Months to 18 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Malaria, Prevention and Control, Acquired Immunity
Interventions: PfSPZ; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 45 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Vascular Disease, Surgery
Interventions: Surgical dressing; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 3
States / cities: Boston, Massachusetts • Houston, Texas

Conditions: Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia
Interventions: Best Practice, Biospecimen Collection, Cytarabine, Electronic Health Record Review, Placebo Administration, Xylitol-containing Oral Wipe; Other · Procedure · Drug
Lead sponsor: Children's Oncology Group; Network
Eligibility: 1 Year to 25 Years
Enrollment: 556 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2033
U.S. locations: 39
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Madera, California + 35 more

Conditions: Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Neuroblastoma, Neutropenia, Sarcoma
Interventions: voriconazole; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 2 Years to 11 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 7
States / cities: Orange, California • San Diego, California • Bethesda, Maryland + 4 more

Conditions: Recurrent Urinary Tract Infection, Urinary Tract Infections, Cystitis Recurrent
Interventions: Vaginal estradiol tablets; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 55 Years to 100 Years · Female only
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: HIV Transmission, Transtheoretical Model of Change
Interventions: PS-PrEP Intervention Group, PrEPLine Control Group; Behavioral
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 35 Years · Male only
Enrollment: 164 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: COVID, Severe Acute Respiratory Syndrome, Sars-CoV2, Acute Kidney Injury, Acute Respiratory Distress Syndrome
Interventions: LSALT peptide, Placebo; Drug
Lead sponsor: Arch Biopartners Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 3
States / cities: San Diego, California • Fort Lauderdale, Florida • Shreveport, Louisiana

Conditions: Microbicide Delivery System Perceptibility and Acceptability
Interventions: Gel, Cream, Liquid; Other
Lead sponsor: The Miriam Hospital; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2022
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Malaria
Interventions: MAM01 1.5 mg/kg, Placebo, MAM01 5 mg/kg, MAM01 10 mg/kg, MAM01 40 mg/kg, MAM01 450 mg, Control, MAM01 600 mg, MAM01 900 mg; Biological · Other
Lead sponsor: Gates Medical Research Institute; Other
Eligibility: 18 Years to 50 Years
Enrollment: 63 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Cytomegalovirus Infections
Interventions: MCMV3068A, MCMV5322A, Placebo; Drug
Lead sponsor: Genentech, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 15
States / cities: Los Angeles, California • San Diego, California • San Francisco, California + 10 more

Conditions: Anthrax
Interventions: BioThrax; Biological
Lead sponsor: Emergent BioSolutions; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 4
States / cities: Miami, Florida • Rochester, New York • Mt. Pleasant, South Carolina + 1 more

Conditions: Sexually Transmitted Infections (Not HIV or Hepatitis), HIV Infections, Sexual Behavior
Interventions: IMARA for Black Male Caregivers and Girls Empowerment, Time-matched control program; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 13 Years and older
Enrollment: 612 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Urinary Tract Infections
Interventions: Gentamicin, Placebo; Drug
Lead sponsor: Gillette Children's Specialty Healthcare; Other
Eligibility: 16 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Surgical Site Infection
Interventions: Ceftaroline, Cefazolin / Vancomycin; Drug
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: Cincinnati, Ohio • West Chester, Ohio

Search by objective public record fields.

AO Multicenter Intervention Trial for Prevention of Surgical Site Infection

Randomized Trial Comparing Irrisept to Saline Irrigation for Infection Prevention

Prevention and Treatment of Frostbite Infection With Antimicrobial Pharmacokinetic Analysis

Technological Home Care: Improving HPN Care With Videophone And Internet Education

Increased Cefazolin During Cesarean Delivery in Obese Population

Nasal Irrigation to Reduce COVID-19 Morbidity

Body Compartment Pharmacokinetics of Anti-retroviral Agents That May be Considered for Future On-demand Peri-exposure HIV Prophylaxis Regimens

Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island

Study of a Potential Preventive Vaccine Against HIV in Healthy Volunteers

rtPA in in the Prevention of CVAD-Associated Thrombosis and Infection in Pediatric Patients With Short Bowel Syndrome

Experimental PfSPZ Vaccine in Adults Without Malaria

Clinical Trial of a Silver Eluting Dressing System

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

Preventing Recurrent UTI With Vaginal Estrogen

Partner Services Pre-exposure Prophylaxis (PS-PrEP)

LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)

Developing Rectal USPE Measures

Safety, Tolerability, Pharmacokinetics and Protective Efficacy of MAM01 in Healthy Adults

A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients

Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults

IMARA for Black Male Caregivers and Girls Empowerment (IMAGE)

Gentamicin Bladder Instillation Trial

The Use of Ceftaroline as Surgical Prophylaxis in Surgery With Risk of MRSA Infection